From: The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis
Parameter | Value |
---|---|
n | 10 |
Sex (male : female) | 7:3 |
Age (years old) | 62.9±4.3 |
Duration of diabetes (years) | 25.4 ± 2.3 |
Duration of HD (years) | 4.1±1.1 |
BMI (kg/m2) | 23.0±1.5 |
Dose of insulin (U/day) | 11.6±1.9 |
Glycated albumin (%) * | 24.1 ± 1.5 |
S-CPR (ng/ml) | 6.7 ± 1.3 |
spKTV | 1.44 ± 0.09 |
Cre (mg/dl) | 9.72±0.91 |
PTH (pg/ml) | 88.0 ± 31.4 |
AST (U/l) | 9.3 ± 1.1 |
ALT (U/l) | 9.7 ± 1.3 |
gGTP (U/l) | 16.9 ± 2.2 |
Total choresterol (mg/dl) | 162.1 ± 8.1 |
Triglyceride (mg/dl) | 120.1 ± 20.6 |
Blood glucose (mg/dl) | 162.1 ± 8.1 |
Complications | Â |
Macroangiopathy (− / +) | (6/4) |
Neuropathy (− / +) | (0/10) |
Retinopathy (− / +) | (0/10) |